TNF and psoriasis: Biological therapies, such as tumor necrosis factor (TNF), interleukin (IL)-17 and IL-23 inhibitors and small molecules allow dermatologists to successfully treat moderate-to-severe psoriasis [7,8,9] and improve patients’ QoL [10,11,12].